ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,318,000 | +46.0% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $903,000 | -1.0% | 180,582 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $912,000 | -18.6% | 180,582 | 0.0% | 0.01% | -11.1% |
| Q3 2017 | $1,120,000 | +72.3% | 180,582 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $650,000 | +10.7% | 180,582 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $587,000 | +32.8% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $442,000 | -28.8% | 180,582 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $621,000 | -1.1% | 180,582 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $628,000 | -15.8% | 180,582 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $746,000 | -7.2% | 180,582 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $804,000 | -26.9% | 180,582 | 0.0% | 0.01% | -30.0% |
| Q3 2015 | $1,100,000 | – | 180,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |